Skip to main content
. 2022 Mar 26;14(4):705. doi: 10.3390/pharmaceutics14040705

Figure 4.

Figure 4

Stability curves over time for (a) VCL-PEGDA-ZnMintPc; (b) VCL/PEGDA-MNPs-MWCNTs-ZnMintPc and (c) VCL/PEGDA-MNPs-GO-ZnMintPc; ZnMintPc = 0.27 µM.